Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This comparison highlights the pros and cons of total market and total world retirement strategies to help you decide which better fits your retirement plan.
28,570 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
AST SpaceMobile has been one of the most volatile names in the space economy. After a dramatic rally, the stock pulle...
In a landscape defined by budget cycles and rapid tech shifts, L3Harris Technologies stands out with a 7.1 rating in ...
A senior MercadoLibre executive recently disclosed an open-market purchase, prompting questions about what this means...
When Apple moves more of its production to the U.S., investors often respond quickly. This article explains why apple...
Broadcom heads into a pivotal Q2 earnings report, with AI demand and data-center growth fueling momentum. This guide ...
Cathie Wood Goes Bargain highlights how Ark Invest’s founder targets beaten-down growth bets for long-term gains. Her...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Explore the 2026 earnings outlook for Quanex (NX) with a clear, investor-friendly analysis. Learn what drives results...
Executives say the path to AI value lies not in squeezing more KPI minutes, but in rethinking how people work. The re...